A multi-component combined micro-pill for time-space release of traditional Chinese medicine and a preparation method thereof
Through the space-time release combination micro-pill technology, the problem of complex components and low bioavailability of rhubarb tragali capsules in the treatment of chronic kidney disease is solved, and the rapid absorption of rhubarb total anthraquinone and astragalus total saponin and colonial localization and release of astragalus polysaccharides are achieved. Improves the therapeutic effect.
Patent Information
- Application Number
- CN202211113989.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2022-09-14
- Publication Date
- 2024-11-15
- Estimated Expiration
- 2042-09-14
AI Technical Summary
When treating chronic kidney disease, Dahuang Huangqi Capsules have problems such as complex ingredients, large dosage, unknown mechanism of action, unclear drug release behavior, unclear pharmacokinetic properties and low oral bioavailability, which affects its efficacy and application.
Using space-time release combined micropill technology, microcrystalline cellulose pill core and fluidized bed coating technology to carry Astragalus polysaccharides, combined with self-microemulsion technology to prepare rhubarb total anthraquinone and astragalus saponins to achieve rhubarb total The gastrointestinal tract of anthraquinone and total astragalus saponin are rapidly released and absorbed, and the colonial localization and release of astragalus polysaccharides is achieved through the principle of pH sensitivity.
The oral absorption and bioavailability of rhubarb total anthraquinone and astragalus total saponin were improved, the gastrointestinal stability of the drug and colon localization and release were ensured, and the treatment effect on chronic kidney disease was enhanced.
Smart Images

Figure CN115590840B_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of pharmaceutical preparations, discloses a Chinese medicine compound preparation for treating and / or improving chronic kidney disease and a preparation method thereof, and specifically relates to a time-space release Chinese medicine multi-component combination micropill and a preparation method thereof. Background Art
[0002] Rhubarb and Astragalus capsules have been used clinically for the treatment of chronic kidney disease (CKD), azotemia and uremia for ten years. However, the complex ingredients, large dosage, unclear material basis and mechanism of action, unclear drug release behavior, unclear pharmacokinetic properties and slow onset of action have restricted the efficacy and wide application of Rhubarb and Astragalus capsules. As a class of organic active entities with a clear composition structure, Chinese medicine "components" have the characteristics of clear unit chemical composition, clear pharmacodynamic mechanism, and consideration of primary and secondary effects. They maintain the advantages of Chinese medicine prescriptions and are consistent with clinical efficacy. Among the many components of rhubarb and Astragalus, total anthraquinones of rhubarb and total saponins of astragalus can delay the development of chronic kidney disease through multiple mechanisms; in addition, according to the "gut-kidney" axis theory, the progression of CKD will lead to intestinal flora imbalance and further aggravate kidney damage. Astragalus polysaccharides, as a prebiotic in astragalus, can effectively regulate intestinal flora and thus play an important role in the progression of chronic kidney disease.
[0003] However, the oral bioavailability of total anthraquinones of rhubarb and astragaloside is low due to poor water solubility and permeability. In addition, the polysaccharides linked by α-glycosidic bonds in astragalus polysaccharides are easily degraded in the stomach and small intestine, making it difficult for them to reach the colon, the largest bacterial reservoir in the human body, to the greatest extent, thus affecting their flora regulation effect. Therefore, finding a method that can effectively improve the intestinal absorption of total anthraquinones of rhubarb and total saponins of astragaloside and achieve colon localization, distribution and drug release of astragalus polysaccharides has important practical significance and application value for optimizing the compatibility effect between components and providing an efficient and reliable treatment strategy for the treatment of chronic kidney disease.
[0004] Self-microemulsifying drug delivery system (SMEDDS) is a homogeneous transparent solution formed by an oil phase, a surfactant and a co-surfactant or a small amount of water. SMEDDS forms a uniform O / W type microemulsion by encapsulating the drug in oil droplets, which disperse spontaneously under gastrointestinal peristalsis when encountering body fluids after oral administration. This system can significantly improve the bioavailability of drugs by increasing the solubility of drugs, reducing surface tension, forming a hydration layer that is easy to pass through the stomach and intestinal walls, and increasing the permeability to intestinal epithelial cells. Making total anthraquinones of rhubarb and total saponins of astragalus into self-microemulsions can effectively improve their solubility and intestinal permeability, thereby improving the oral absorption and bioavailability of the two. In addition, micropellets as a carrier for drug delivery combined with different drug release principles for coating can achieve the diversity of drug release performance, and can also meet the diversified needs of releasing multiple components of traditional Chinese medicine at different times and in different parts.
[0005] Here, we Summary of the invention
[0006] In order to solve the diversified demand problems of releasing rhubarb-astragalus multi-components at different times and in different parts, this patent proposes a time-space release combination micropill for delivering rhubarb-astragalus multi-components. The combination micropill uses microcrystalline cellulose pellet core as the mother core, uses fluidized bed coating to achieve the encapsulation of astragalus polysaccharide, and performs colon-targeted coating based on the time-lag-pH sensitive principle to achieve colon-targeted release of astragalus polysaccharide, thereby improving the gastrointestinal stability of astragalus polysaccharide; self-microemulsion of total anthraquinones of rhubarb-total saponins of astragalus is prepared by self-microemulsion technology to effectively improve the oral absorption of the two; with colon-targeted astragalus polysaccharide micropills as the mother core, fluidized bed solidification self-microemulsion is used to prepare time-space release of traditional Chinese medicine multi-component combination micropills. The combination micropill can achieve rapid gastrointestinal release and absorption of total anthraquinones of rhubarb and total saponins of astragalus, and can achieve colon-targeted release of astragalus polysaccharide, thereby improving its gastrointestinal stability and giving full play to the comprehensive effects of rhubarb-astragalus multi-components.
[0007] The invention prepares a time-space release combined micropill, which can ensure the rapid release of total anthraquinones of rhubarb and total saponins of astragalus in the stomach and promote the oral absorption of the two, while achieving the slow release of astragalus polysaccharide in the colon.
[0008] The present invention provides a time-space release combined micropill and a preparation method thereof, comprising the following contents:
[0009] A multi-component combined micro-pill of traditional Chinese medicine for time-space release, the micro-pill comprising a blank core, a drug layer I, a sustained-release coating layer, a pH-responsive coating layer, and a drug layer II from the inside to the outside; the main drug is total anthraquinone of rhubarb: total saponins of astragalus:
[0010] The weight ratio of astragalus polysaccharide is 1:(0.2-5):(9-45);
[0011] The drug layer I is astragalus polysaccharide;
[0012] The drug layer II includes total anthraquinones of rhubarb and total saponins of astragalus, as well as one or more of ethyl oleate, EL35, ethylene glycol, micro-powder silica gel and water; the weight percentage of total anthraquinones of rhubarb is 0.5% to 1%, and the weight percentage of total saponins of astragalus is 0.5% to 1%.
[0013] Preferably, the blank pellet cores in the time-space-released Chinese medicine multi-component combination pellets are selected from one or more of microcrystalline cellulose pellet cores, starch pellet cores, pre-coated starch pellet cores, and sucrose pellet cores.
[0014] Preferably, the weight gain range of the sustained-release coating layer in the time-space-released traditional Chinese medicine multi-component combination micropellets is 5% to 20%.
[0015] Preferably, the weight gain range of the pH-responsive coating layer in the time-space-released traditional Chinese medicine multi-component combination micropellets is 17% to 70%.
[0016] Preferably, the weight ratio of total anthraquinones of rhubarb to total saponins of astragalus in drug layer II of the time-space release traditional Chinese medicine multi-component combination micropill is in the range of 1:0.2 to 1:5, the weight percentage of total anthraquinones of rhubarb in drug layer II is 0.5% to 1%; the weight percentage of total saponins of astragalus in drug layer II is 0.5% to 1%; the drug layer II also includes one or more of ethyl oleate, EL35, ethylene glycol, micropowder silica gel, and water.
[0017] Preferably, the drug layer II in the time-space release Chinese medicine multi-component combination micropill contains the following substances in parts by weight: 5-10 parts of total anthraquinones of rhubarb, 5-10 parts of total saponins of astragalus, 10-50 parts of ethyl oleate, 9-81 parts of EL35, 7-81 parts of ethylene glycol, and 5-20 parts of micro-powder silica gel.
[0018] Preferably, the sustained-release coating layer and the pH-responsive coating layer in the time-space release combination micropellets have different compositions in the same formulation.
[0019] Preferably, the sustained-release coating liquid used for the sustained-release coating layer in the time-space-released traditional Chinese medicine multi-component combination micropellets is METHOCEL or Opadry, preferably METHOCEL; the preferred weight gain range of the sustained-release coating layer is 5% to 20%.
[0020] Preferably, the ingredients of the pH-responsive coating layer in the time-space-released traditional Chinese medicine multi-component combination micropellets include one or more of Opadry (enteric-soluble), Opadry (gastric-soluble) hydroxypropyl cellulose (low, medium, high).
[0021] Preferably, the method for preparing the time-space release combined micropills comprises the following steps:
[0022] (1) Preparation of drug-loaded micropellets I:
[0023] Adding the formula amount of astragalus polysaccharide into purified water under stirring and stirring evenly to obtain an astragalus polysaccharide solution, spraying the solution onto the blank pellet core to obtain drug-loaded I pellets;
[0024] (2) Preparation of sustained-release coated pellets:
[0025] Add the coating solution of the formula amount into purified water and stir evenly to obtain the coating solution of the sustained-release coating layer, and spray the coating solution of the sustained-release coating layer onto the drug I micropellets prepared in step (1) to obtain sustained-release coated micropellets;
[0026] (3) Preparation of pH-responsive micropellets:
[0027] Adding the formulated amount of pH-responsive coating layer into purified water and stirring the mixture to obtain a pH-responsive coating solution, spraying the coating solution onto the micropellets prepared in step (2) to obtain pH-responsive micropellets;
[0028] (4) Preparation of combined micropellets with time-space release:
[0029] Under stirring, add the formula amount of ricinoleate (EL35), ethylene glycol, and ethyl oleate to a beaker and stir evenly, add the formula amount of total anthraquinones of rhubarb and total saponins of astragalus in turn, and after stirring evenly, ultrasonicate for 2 hours to obtain the total anthraquinones of rhubarb and total saponins of astragalus self-microemulsion concentrate. Subsequently, add the formula amount of pure water and micropowder silica gel under stirring to obtain a self-microemulsion drug solution, and spray the above drug solution on the pH-responsive micropills to obtain the time-space release combination micropills.
[0030] More specifically, the present invention is achieved through the following technical solutions:
[0031] The invention provides a time-space release combined micropill, which comprises a blank core, a drug layer I, a sustained-release coating layer, a pH-responsive coating layer, and a drug layer II from the inside to the outside; the weight ratio of the main drug total anthraquinones of rhubarb: total saponins of astragalus: astragalus polysaccharide is 1: (0.2-5): (9-45).
[0032] In some embodiments, the blank pellet cores of the present invention are selected from one or more of microcrystalline cellulose pellet cores, starch pellet cores, pre-coated starch pellet cores, and sucrose pellet cores.
[0033] In some embodiments, the weight percentage of astragalus polysaccharide in the drug layer I is 100%.
[0034] The weight gain of drug layer I can be calculated according to the drug dosage.
[0035] In some embodiments, the weight ratio of total anthraquinones of rhubarb to total saponins of astragalus in the drug layer II is in the range of 1:0.2 to 1:5, preferably 1:1 to 1:2; the weight percentage of total anthraquinones of rhubarb in the drug layer II is 0.5% to 1%, preferably 0.5% to 0.7%; the weight percentage of total saponins of astragalus in the drug layer II is 0.5% to 1%, preferably 0.5% to 0.9%; the drug layer II also includes one or more of ethyl oleate, EL35, ethylene glycol, micropowder silica gel, and water.
[0036] In some specific embodiments, drug layer II contains the following substances in parts by weight: Most preferably, drug layer II contains the following substances in parts by weight: 5-10 parts of total anthraquinones of rhubarb, 5-10 parts of total saponins of astragalus, 10-50 parts of ethyl oleate, 9-81 parts of EL35, 7-81 parts of ethylene glycol, and 5-20 parts of micro-powder silica gel; preferably, 5-6 parts of total anthraquinones of rhubarb, 5-9 parts of total saponins of astragalus, 20-30 parts of ethyl oleate, 40-50 parts of EL35, 20-30 parts of ethylene glycol, and 5-10 parts of micro-powder silica gel.
[0037] The weight gain range of drug layer II can be calculated according to the drug dosage.
[0038] In some embodiments, the sustained-release coating layer and the pH-responsive coating layer are different in the same formulation, and the sustained-release component is one or more of Opadry and METHOCEL. METHOCEL is preferred. The pH-responsive coating component is one or more of Opadry (enteric), Opadry (gastric) hydroxypropyl cellulose (low, medium, high).
[0039] In some embodiments, the sustained-release coating layer has a weight gain range of 5% to 20%, preferably 10% to 20%.
[0040] In some embodiments, the pH-responsive coating layer has a weight gain range of 17% to 70%, preferably 17% to 20%. The present invention also provides a method for preparing the above-mentioned time-space release combined micropellets, comprising the following steps:
[0041] (1) Preparation of Drug I Pellets:
[0042] Adding the formula amount of astragalus polysaccharide into purified water and stirring evenly to obtain an astragalus polysaccharide solution, spraying the solution onto the blank pellet core to obtain drug I pellets;
[0043] (2) Preparation of sustained-release coated pellets:
[0044] Add the formulated amount of coating liquid into purified water and stir evenly to obtain a sustained-release coating liquid, which is spray-coated on the drug-containing layer 1 micropellets prepared in step (1) to obtain sustained-release coated micropellets;
[0045] (3) Preparation of pH-responsive coated pellets:
[0046] Under stirring, the components of the pH-responsive coating in the formula are sequentially or simultaneously added into purified water and stirred evenly to form a pH-responsive coating solution, which is spray-coated onto the sustained-release coated micropellets to obtain pH-responsive coated micropellets;
[0047] (4) Preparation of combined micropellets:
[0048] Under stirring, add the formula amount of EL35 and ethylene glycol to ethyl oleate and stir evenly, after stirring evenly, add the formula amount of total anthraquinones of rhubarb and total saponins of astragalus in sequence, after the total anthraquinones of rhubarb and total saponins of astragalus are completely dissolved, add the obtained self-microemulsion and the formula amount of micro powder silica gel into pure water and stir evenly to obtain a self-microemulsion drug solution, spray the above drug solution on the pH-responsive coated micropellets to obtain time-space release Chinese medicine multi-component combination micropellets;
[0049] The preparation method of the present invention and the formula of each layer are as described above.
[0050] In a specific embodiment of the present invention, the present invention also provides a more specific method for preparing the time-space release combined micropills, the steps are as follows:
[0051] (1) Drug I pellets prescription and preparation:
[0052] Excipients Dosage Astragalus polysaccharide 100%
[0053] ① Add the astragalus polysaccharide into purified water under stirring, stir evenly, and set aside;
[0054] ② Spray the above-mentioned drug solution onto the blank pill core to obtain drug I-containing micropellets, and dry them.
[0055] (2) Prescription and preparation of sustained-release pellets:
[0056] Excipients Dosage Drug I Pellets 80~95% Metoshow 5%~20%
[0057] ① Add the above-mentioned METHOCEL into purified water, stir evenly and set aside;
[0058] ② Spray the above-mentioned METHOCEL coating solution onto the above-mentioned drug I pellets to obtain sustained-release pellets;
[0059] (3) pH responsive pellets formulation and preparation:
[0060] Excipients Dosage Sustained Release Pellets 30~83% Opadry (Enteric Coated) 17%~70%
[0061] ① Add the above Opadry into purified water and stir evenly for later use;
[0062] ② Spray the above-mentioned Opadry coating solution onto the above-mentioned sustained-release micropellets to obtain pH-responsive micropellets;
[0063] (4) Prescription of multi-component combination micropellets of traditional Chinese medicine for spatiotemporal release
[0064] Excipients Dosage pH Responsive Pellets 20%~23.75% Total Anthraquinones in Rhubarb 0.378%~0.75% Astragalus total saponins 0.378%~0.75% Ethyl oleate 7.5%~37.5% EL35 6.75%~60.75% Ethylene glycol 5.25%~60.75% Micro powder silica gel 1.25%~5%
[0065] ① Add the EL35 and ethylene glycol to ethyl oleate under stirring, stir evenly, and set aside;
[0066] ②Add the total anthraquinones of rhubarb and total saponins of astragalus in the formula amount in sequence and set aside;
[0067] ③ After the total anthraquinones of rhubarb and the total saponins of astragalus are completely dissolved, the obtained self-microemulsion and the formulated amount of micro-powdered silica gel are added into pure water and stirred evenly to obtain a self-microemulsion drug solution;
[0068] ③ The above-mentioned drug solution is spray-coated on the pH-responsive micro-pellets to obtain multi-component combination micro-pellets of traditional Chinese medicine for spatiotemporal release;
[0069] The advantages of the micro-pellets of the present invention over the prior art are:
[0070] ① The micro-pills of the present invention can reduce the irritation of traditional Chinese medicine to the digestive tract, cover up the bad smell of traditional Chinese medicine, and are easy to swallow, thereby improving patient compliance;
[0071] ② The micropills of the present invention have stable and controllable drug release. As a dose-dispersed multi-component preparation, the micropills are less affected by gastric emptying factors after oral administration, and the drug absorption rate is uniform;
[0072] ③ The self-microemulsification speed of the present invention is fast, the particle size is small, the dissolution is fast, and the formed nano-scale emulsion droplets have a large interfacial area, which can better pass through the gastrointestinal mucosa and can be absorbed through the submucosal lymph, which can significantly increase the absorption of total anthraquinones of rhubarb and total saponins of astragalus, and improve the therapeutic effect;
[0073] ④ The present invention uses fluidized coating technology to solidify the liquid self-microemulsion into micropellets, which can not only improve the shortcomings of self-microemulsion stability, gastrointestinal irritation, and inconvenience in carrying, but also control the drug release rate;
[0074] ⑤ The combined micropills described in the present invention can achieve the colon-localized slow release of astragalus polysaccharide while taking into account the rapid release of total anthraquinones of rhubarb and total saponins of astragalus, thereby effectively realizing the synergistic enhancement of multiple components of traditional Chinese medicine and providing an efficient comprehensive treatment strategy for the treatment of chronic kidney disease. BRIEF DESCRIPTION OF THE DRAWINGS
[0075] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative labor.
[0076] Figure 1 PEG400 (A), propylene glycol (B), and ethylene glycol (C) according to an embodiment of the present invention are used as auxiliary emulsifiers in a ternary phase diagram.
[0077] Figure 2 It is a transmission electron microscope image of the self-microemulsion of an embodiment of the present invention.
[0078] Figure 3 Graph showing the effect of weight gain of Opadry coating on the antacid effect of an embodiment of the present invention.
[0079] Figure 4 Graph showing the effect of METHOCEL coating weight gain on sustained-release effect in an embodiment of the present invention.
[0080] Figure 5 This is the appearance and scanning electron microscope image of the Astragalus polysaccharide colon-targeted micropills and the time-space release combined micropills of the embodiments of the present invention.
[0081] Figure 6 It is the XRD spectrum of the astragalus polysaccharide colon-targeted micropills and the time-space release combined micropills of the embodiments of the present invention.
[0082] Figure 7 This is an in vitro release diagram of the spatiotemporal release combination micropills according to an embodiment of the present invention. DETAILED DESCRIPTION
[0083] The present invention is further described in detail below in conjunction with embodiments. The following embodiments are for explanation of the present invention but the present invention is not limited to the following embodiments.
[0084] Example:
[0085] The test materials used in the following examples, unless otherwise specified, are purchased from conventional biochemical reagent stores. This example is only used to illustrate the present invention and is not intended to limit the present invention. After reading the contents of the present invention, those skilled in the art may make various changes or modifications to the present invention, and these equivalent changes and modifications also fall within the scope defined by the claims of the present invention.
[0086] Step 1: Preparation of Astragalus polysaccharide colon-targeted pellets
[0087] (1) Preparation of Astragalus Polysaccharide Pellets:
[0088] 20.0 g of astragalus polysaccharide was added to 100 mL of purified water under stirring and stirred evenly to obtain a 10% by mass astragalus polysaccharide solution, and the solution was spray-coated on 20.0 g of blank pellets to obtain astragalus polysaccharide pellets;
[0089] The weight percentage of each component in the astragalus polysaccharide micro-pellets is as follows: the blank pellet core accounts for 50%, and the astragalus polysaccharide accounts for 50%.
[0090] (2) Preparation of Astragalus polysaccharide sustained-release micropellets.
[0091] 80.0 g of METHOCEL was added into 400 mL of purified water and stirred evenly, wherein the concentration of METHOCEL was 20%. The sustained-release coating solution was sprayed onto 20.0 g of astragalus polysaccharide pellets to obtain astragalus polysaccharide sustained-release pellets.
[0092] The sustained-release coated pellets gained 20% weight.
[0093] (3) Preparation of Astragalus polysaccharide colon-targeted pellets:
[0094] Under stirring, 20.0 g of pH-responsive coating layer (Opadry-Enteric) was added to 100 mL of purified water and stirred evenly as pH-responsive coating solution, which was spray-coated on the sustained-release coated pellets to obtain Astragalus polysaccharide colon-targeted pellets.
[0095] The pH responsive coating layer gained 18% weight.
[0096] Step 2: Preparation of multi-component micropellets for spatiotemporal release
[0097] (4) Preparation of multi-component combination micropellets with spatiotemporal release:
[0098] Under stirring, add 9.00g EL35 and 5.50g ethylene glycol to 5.90g ethyl oleate and stir evenly. After stirring evenly, add 85.0mg total anthraquinones of rhubarb and 175mg total saponins of astragalus in sequence. After the total anthraquinones of rhubarb and total saponins of astragalus are completely dissolved, add the obtained self-microemulsion and 5.00g micro-powder silica gel to 100mL pure water and stir evenly to obtain a self-microemulsion drug solution. Spray the above drug solution on the 20.0g pH response coating layer to obtain multi-component combination micropellets containing time-space release of traditional Chinese medicine;
[0099] The weight proportions of each substance in the multi-component combination micropills of traditional Chinese medicine for time-space release are as follows: total anthraquinones of rhubarb account for 0.19%, total saponins of astragalus account for 0.39%, micropowder silica gel accounts for 11.11%, ethylene glycol accounts for 12.28%, ethyl oleate accounts for 13.16%, EL35 accounts for 18.42%, Opadry-Enteric Coated accounts for 6.78%, Medocel accounts for 6.28%, astragalus polysaccharides account for 15.69%, and blank pill core accounts for 15.69%.
[0100] In addition, it should be noted that the content of each component of the specific embodiments described in this specification can be adjusted within the scope of protection of this patent. This does not require creative work for ordinary technicians in this field. This embodiment is just one of many embodiments. All equivalent or simple changes made according to the process and principle described in the patent concept of the present invention are included in the protection scope of the patent of the present invention. Technicians in the technical field to which the present invention belongs can make various modifications or supplements to the specific embodiments described or replace them in a similar manner. As long as they do not deviate from the structure of the present invention or exceed the scope defined by the claims, they should all fall within the protection scope of the present invention.
Claims
1. A multi-component combined micro-pellet of traditional Chinese medicine for time-space release, characterized in that: The micro-pellets include a blank core, a drug layer I, a sustained-release coating layer, a pH-responsive coating layer, and a drug layer II from the inside to the outside; the weight ratio of the main drug total anthraquinone of rhubarb: total saponin of astragalus: astragalus polysaccharide is 1: (0.2-5): (9-45); The drug layer I is astragalus polysaccharide; The drug layer II includes total anthraquinones of rhubarb and total saponins of astragalus, as well as ethyl oleate, EL35, ethylene glycol, and micro-powdered silica gel; based on the total amount of the combined micro-pellets, the weight percentage of total anthraquinones of rhubarb is 0.5% to 1%, and the weight percentage of total saponins of astragalus is 0.5% to 1%; The sustained-release coating liquid used in the sustained-release coating layer is Medocel; the component of the pH-responsive coating layer is enteric-coated Opadry; the weight gain range of the sustained-release coating layer is 5% to 20%; the weight gain range of the pH-responsive coating layer is 17% to 20%; the drug layer II contains the following substances in parts by weight: 5 to 10 parts of total anthraquinones of rhubarb, 5 to 10 parts of total saponins of astragalus, 10 to 50 parts of ethyl oleate, 9 to 81 parts of EL35, 7 to 81 parts of ethylene glycol, and 5 to 20 parts of micro-powdered silica gel; The combined micropill uses microcrystalline cellulose pellet core as the mother core, adopts fluidized bed coating to achieve the encapsulation of astragalus polysaccharide, and performs colon-targeted coating based on the time-lag-pH sensitivity principle. The self-microemulsion technology is used to prepare the total anthraquinone of rhubarb-total saponin of astragalus. The colon-targeted astragalus polysaccharide micropill is used as the mother core, and the fluidized bed solidification self-microemulsion is used to prepare the time-space release of traditional Chinese medicine multi-component combined micropill.
2. The method for preparing the time-space release combined micropills according to claim 1, comprising the following steps: (1) Preparation of drug-loaded micropellets I: Adding the formula amount of astragalus polysaccharide into purified water under stirring and stirring evenly to obtain an astragalus polysaccharide solution, spraying the solution onto the blank pellet core to obtain drug-loaded I micropellets; (2) Preparation of sustained-release coated pellets: Add the coating solution of the formula amount into purified water and stir evenly to obtain the coating solution of the sustained-release coating layer, and spray the coating solution of the sustained-release coating layer onto the drug I micropellets prepared in step (1) to obtain sustained-release coated micropellets; (3) Preparation of pH-responsive micropellets: Adding the formulated amount of pH-responsive coating layer into purified water and stirring the mixture to obtain a pH-responsive coating solution, spraying the coating solution onto the micropellets prepared in step (2) to obtain pH-responsive micropellets; (4) Preparation of combined micropellets with time-space release: Under stirring condition, add the formula amount of ricinoleate EL35, ethylene glycol and ethyl oleate into a beaker and stir evenly, then add the formula amount of total anthraquinones of rhubarb and total saponins of astragalus in sequence, and after stirring evenly, ultrasonicate for 2 h to obtain the self-microemulsification concentrate of total anthraquinones of rhubarb and total saponins of astragalus, then add the formula amount of pure water and micropowder silica gel under stirring to obtain the self-microemulsification drug solution, and spray the above drug solution on the pH responsive micropills to obtain the time-space release combination micropills.
Citation Information
Patent Citations
A multicompartment hard capsule with control release properties
CA2201924A1
Budesonide intestines sustained release dextromethorphan pellets and method of manufacturing the same
CN101108171A
Double-coating cyclosporine A sustained-release pellet preparation and preparation method thereof
CN104717963A
Quick-release or controlled-release hedyotis uncinella pellet capsule and preparation method thereof
CN106266068A
Oral colon-specific preparation for preventing and treating ulcerative colitis
CN113616619A
